{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:06Z","timestamp":1772136366679,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China Special Program for Cultivation of the Third Affiliated Hospital of Sun Yat-sen University","award":["2021GZRPYMS06"],"award-info":[{"award-number":["2021GZRPYMS06"]}]},{"name":"Five-five Project of the Third Affiliated Hospital of Sun Yat-sen University","award":["2023WW605"],"award-info":[{"award-number":["2023WW605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91902-3","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:00:20Z","timestamp":1741057220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between imaging features of pure ground-glass opacities and pathological subtypes of lung minimally invasive adenocarcinoma and precursor lesions"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanqiu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"91902_CR1","doi-asserted-by":"crossref","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.1\u201341 (2021).","DOI":"10.3322\/caac.21660"},{"key":"91902_CR2","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng, H. et al. Changing cancer survival in China during 2003-15: A pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6, e555\u2013e567 (2018).","journal-title":"Lancet Glob. Health"},{"key":"91902_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-1-60327-492-0_19","volume":"472","author":"C Toh","year":"2009","unstructured":"Toh, C. The changing epidemiology of lung cancer. Methods Mol. Biol. 472, 397\u2013411 (2009).","journal-title":"Methods Mol. Biol."},{"key":"91902_CR4","first-page":"19","volume":"41","author":"R Zheng","year":"2019","unstructured":"Zheng, R. et al. Analysis of the prevalence of malignant tumors in China in 2015. Zhong Hua Zhong Liu Za Zhi 41, 19\u201328 (2019).","journal-title":"Zhong Hua Zhong Liu Za Zhi"},{"key":"91902_CR5","first-page":"707","volume":"34","author":"HK Kim","year":"2014","unstructured":"Kim, H. K. et al. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for targetdirected therapy. Anticancer Res. 34, 707\u2013714 (2014).","journal-title":"Anticancer Res."},{"issue":"8","key":"91902_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","volume":"31","author":"WD Travis","year":"2013","unstructured":"Travis, W. D., Brambilla, E. & Riely, G. J. New pathologic classification of lung cancer: Relevance for clinical practice and clinical trials. J. Clin. Oncol. 31(8), 992\u20131001 (2013).","journal-title":"J. Clin. Oncol."},{"key":"91902_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis, W. D. et al. International association for the study of lung Cancer\/american thoracic Society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 6, 244\u2013285 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"91902_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D. et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243\u20131260 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"91902_CR9","unstructured":"WHO Classification of Tumours Editorial Board. Thoracic Tumours WHO Classification of Tumours 5th edn, Vol. 5 (World Health Organization, 2021). Available at: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Thoracic-Tumours-2021."},{"key":"91902_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jtcvs.2016.01.029","volume":"151","author":"CL Wilshire","year":"2016","unstructured":"Wilshire, C. L. et al. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience. J. Thorac. Cardiovasc. Surg. 151, 1561\u20131568 (2016).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"91902_CR11","first-page":"445","volume":"24","author":"Y Li","year":"2017","unstructured":"Li, Y., Chen, Z., Yu, W. & Zhang, Y. Clinicopathology and prognosis of 489 patients with adenocarcinoma in situ and minimally invasive adenocarcinoma of lung. Zhong Guo Xiong Xin Xue Guan Wai Ke Lin Chuang Za Zhi. 24, 445\u2013449 (2017).","journal-title":"Zhong Guo Xiong Xin Xue Guan Wai Ke Lin Chuang Za Zhi"},{"key":"91902_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/jso.23259","volume":"107","author":"J Gu","year":"2013","unstructured":"Gu, J. et al. Prognostic significance of the IASLC\/ATS\/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma. J. Surg. Oncol. 107, 474\u2013480 (2013).","journal-title":"J. Surg. Oncol."},{"key":"91902_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"PA Russell","year":"2011","unstructured":"Russell, P. A. et al. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new international association for the study of lung Cancer\/American thoracic society\/European respiratory society international multidisciplinary lung adenocarcinoma classification. J. Thorac. Oncol. 6, 1496\u20131504 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"91902_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.lungcan.2013.06.012","volume":"81","author":"K Tsuta","year":"2013","unstructured":"Tsuta, K. et al. The utility of the proposed IASLC\/ATS\/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 81, 371\u2013376 (2013).","journal-title":"Lung Cancer"},{"key":"91902_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/modpathol.2010.232","volume":"24","author":"A Yoshizawa","year":"2011","unstructured":"Yoshizawa, A. et al. Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod. Pathol. 24, 653\u2013664 (2011).","journal-title":"Mod. Pathol."},{"issue":"8","key":"91902_CR16","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1245\/s10434-020-08241-y","volume":"27","author":"M Jia","year":"2020","unstructured":"Jia, M. et al. Clinicopathologic features and genetic alterations in adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: Long-term follow-up study of 121 Asian patients. Ann. Surg. Oncol. 27(8), 3052\u20133063 (2020).","journal-title":"Ann. Surg. Oncol."},{"key":"91902_CR17","first-page":"167","volume":"36","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. & Yu, J. Review of radiomics in lung adenocarcinoma manifesting as ground glass nodule. Zhong Guo Yi Liao She Bei. 36, 167\u2013171 (2021).","journal-title":"Zhong Guo Yi Liao She Bei"},{"key":"91902_CR18","first-page":"435","volume":"46","author":"X Zhu","year":"2018","unstructured":"Zhu, X. et al. The value of CT in the early diagnosis of ground-glass pulmonary nodules. Zhong Guo Lin Chuang Yi Sheng Za Zhi. 46, 435\u2013437 (2018).","journal-title":"Zhong Guo Lin Chuang Yi Sheng Za Zhi"},{"key":"91902_CR19","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","volume":"368","author":"National Lung Screening Trial Research Team","year":"2013","unstructured":"National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N. Engl. J. Med. 368, 1980\u20131991 (2013).","journal-title":"N. Engl. J. Med."},{"key":"91902_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.ejrad.2016.07.012","volume":"85","author":"MJ Si","year":"2016","unstructured":"Si, M. J. et al. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity. Eur. J. Radiol. 85, 1708\u20131715 (2016).","journal-title":"Eur. J. Radiol."},{"key":"91902_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell, D. M. et al. Fleischner society: Glossary of terms for thoracic imaging. Radiology 246, 697\u2013722 (2008).","journal-title":"Radiology"},{"key":"91902_CR22","first-page":"793","volume":"26","author":"Z Wang","year":"2018","unstructured":"Wang, Z. & Xu, G. The radiology, pathology and clinical management of grand-glass opacity lung nodules. Xian Dai Zhong Liu Yi Xue. 26, 793\u2013796 (2018).","journal-title":"Xian Dai Zhong Liu Yi Xue"},{"key":"91902_CR23","doi-asserted-by":"publisher","first-page":"14586","DOI":"10.1038\/s41598-019-50989-1","volume":"9","author":"L Qi","year":"2019","unstructured":"Qi, L. et al. Analysis of CT morphologic features and Attenuation for diferentiating among transient lesions, atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive and invasive adenocarcinoma presenting as pure ground-glass nodules. Sci. Rep. 9, 14586 (2019).","journal-title":"Sci. Rep."},{"key":"91902_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/AJR.19.22381","volume":"215","author":"ZG Chu","year":"2020","unstructured":"Chu, Z. G., Li, W. J., Fu, B. J. & Lv, F. J. CT characteristics for predicting invasiveness in pulmonary pure ground-glass nodules. AJR Am. J. Roentgenol. 215, 351\u2013358 (2020).","journal-title":"AJR Am. J. Roentgenol."},{"key":"91902_CR25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.athoracsur.2017.11.012","volume":"105","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Nomogram for predicting the risk of invasive pulmonary adenocarcinoma for pure ground-glass nodules. Ann. Thorac. Surg. 105, 1058\u20131064 (2018).","journal-title":"Ann. Thorac. Surg."},{"key":"91902_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jtcvs.2019.10.145","volume":"160","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Results of low-dose computed tomography as a regular health examination among Chinese hospital employees. J. Thorac. Cardiovasc. Surg. 160, 824\u2013831 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"91902_CR27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fonc.2020.01059","volume":"10","author":"X Li","year":"2020","unstructured":"Li, X. et al. The epidemiology of ground glass opacity lung adenocarcinoma: A network-based cumulative meta-analysis. Front. Oncol. 10, 1059 (2020).","journal-title":"Front. Oncol."},{"key":"91902_CR28","doi-asserted-by":"crossref","unstructured":"Lin, H. T. et al. Epidemiology and survival outcomes of lung cancer a population-based study. BioMed. Research. Int. 1\u201319 (2019).","DOI":"10.1155\/2019\/8148156"},{"key":"91902_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JTO.0b013e3182769aa8","volume":"8","author":"A Yoshizawa","year":"2013","unstructured":"Yoshizawa, A. et al. Validation of the IASLC\/ATS\/ERS lungadenocarcinomaclassification forprognosis and association with EGFR and KRAS gene mutations: Analysis of 440 Japanese patients. J. Thorac. Oncol. 8, 52\u201361 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"91902_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2015.63.4907","volume":"34","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral Small-Sized lung adenocarcinoma. J. Clin. Oncol. 34, 307\u2013313 (2016).","journal-title":"J. Clin. Oncol."},{"key":"91902_CR31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jtcvs.2013.09.065","volume":"147","author":"NK Altorki","year":"2014","unstructured":"Altorki, N. K. et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J. Thorac. Cardiovasc. Surg. 147, 754\u2013762 (2014).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"91902_CR32","first-page":"67","volume":"44","author":"S Wang","year":"2021","unstructured":"Wang, S., Fu, Z. & Qiu, J. Progress in the diagnosis of lung adenocarcinoma manifesting as ground glass nodule. Guo Ji Yi Xue Fang She Xue Za Zhi 44, 67\u201371 (2021).","journal-title":"Guo Ji Yi Xue Fang She Xue Za Zhi"},{"key":"91902_CR33","first-page":"93","volume":"20","author":"M Hara","year":"2002","unstructured":"Hara, M. et al. Focal fibrosis as a cause of localized ground glass Attenuation (GGA)\u2014CT and MR findings. Radiat. Med. 20, 93\u201395 (2002).","journal-title":"Radiat. Med."},{"key":"91902_CR34","doi-asserted-by":"publisher","first-page":"W162","DOI":"10.2214\/AJR.18.21008","volume":"213","author":"Y Zhan","year":"2019","unstructured":"Zhan, Y. et al. Attenuation and morphologic characteristics distinguishing a Ground-Glass nodule measuring 5\u201310\u00a0mm in diameter as invasive lung adenocarcinoma on Thin-Slice CT. AJR Am. J. Roentgenol. 213, W162\u2013W170 (2019).","journal-title":"AJR Am. J. Roentgenol."},{"key":"91902_CR35","doi-asserted-by":"publisher","first-page":"14586","DOI":"10.1038\/s41598-019-50989-1","volume":"9","author":"L Qi","year":"2019","unstructured":"Qi, L. et al. Analysis of CT morphologic features and Attenuation for differentiating among transient lesions, atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive and invasive adenocarcinoma presenting as pure ground-glass nodules. Sci. Rep. 9, 14586 (2019).","journal-title":"Sci. Rep."},{"key":"91902_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejrad.2019.02.034","volume":"113","author":"T Zhang","year":"2019","unstructured":"Zhang, T. et al. Histogram analysis combined with morphological characteristics to discriminate adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma appearing as pure ground-glass nodule. Eur. J. Radiol. 113, 238\u2013244 (2019).","journal-title":"Eur. J. Radiol."},{"key":"91902_CR37","doi-asserted-by":"publisher","first-page":"e0180502","DOI":"10.1371\/journal.pone.0180502","volume":"12","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules? PLoS One 12, e0180502 (2017).","journal-title":"PLoS One"},{"key":"91902_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11604-013-0264-y","volume":"32","author":"A Kamiya","year":"2014","unstructured":"Kamiya, A. et al. Kurtosis and skewness assessments of solid lung nodule density histograms: Diferentiating malignant from benign nodules on CT. Jpn. J. Radiol. 32, 14\u201321 (2014).","journal-title":"Jpn. J. Radiol."},{"key":"91902_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40644-014-0033-x","volume":"14","author":"W Xiang","year":"2014","unstructured":"Xiang, W. et al. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring \u2264 10\u00a0mm on thin-section computed tomography. Cancer Imaging. 14, 33 (2014).","journal-title":"Cancer Imaging"},{"key":"91902_CR40","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","volume":"30","author":"A Warth","year":"2012","unstructured":"Warth, A. et al. The novel histologic international association for the study of lung Cancer\/American thoracic society\/European respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J. Clin. Oncol. 30, 1438\u20131446 (2012).","journal-title":"J. Clin. Oncol."},{"key":"91902_CR41","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/PAS.0000000000000399","volume":"39","author":"G Lee","year":"2015","unstructured":"Lee, G. et al. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: Prognostic significance and survival outcomes. Am. J. Surg. Pathol. 39, 660\u2013666 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"91902_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijscr.2020.03.021","volume":"70","author":"Y Honda","year":"2020","unstructured":"Honda, Y. et al. Mediastinal lymph node metastases in lung cancer presenting as pure ground-glass nodules: A surgical case report. Int. J. Surg. Case Rep. 70, 5\u20137 (2020).","journal-title":"Int. J. Surg. Case Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91902-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:00:32Z","timestamp":1741057232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91902-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91902-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4441551\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7572"}}